跳至主要内容
临床试验/IRCT20170117032025N9
IRCT20170117032025N9尚未招募2 期

Study of the therapeutic effect of the combination of altplas and ibtifibatide (integrilin) in comparison with altplas (r-TPA) alone, in the treatment of acute ischemic stroke

Hamedan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients should have a serious measurable neurological defect on the NIHSS stroke scale due to focal ischemia of the brain (NIHSS score> 5).
  • Intravenous therapy should be started within 3 hours of the onset of stroke symptoms.

排除标准

  • Suspect subarachnoid hemorrhage, even if the brain CT scan is normal

研究者

相似试验